183 related articles for article (PubMed ID: 8100827)
1. Regulation of free fatty acid metabolism by glucagon.
Carlson MG; Snead WL; Campbell PJ
J Clin Endocrinol Metab; 1993 Jul; 77(1):11-5. PubMed ID: 8100827
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucagon on free fatty acid metabolism in humans.
Jensen MD; Heiling VJ; Miles JM
J Clin Endocrinol Metab; 1991 Feb; 72(2):308-15. PubMed ID: 1991802
[TBL] [Abstract][Full Text] [Related]
3. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
4. Effect of fatty acids on glucose production and utilization in man.
Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
[TBL] [Abstract][Full Text] [Related]
5. Glucose regulation of lipid metabolism in humans.
Carlson MG; Snead WL; Hill JO; Nurjhan N; Campbell PJ
Am J Physiol; 1991 Dec; 261(6 Pt 1):E815-20. PubMed ID: 1767842
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
[TBL] [Abstract][Full Text] [Related]
7. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
Fanelli C; Calderone S; Epifano L; De Vincenzo A; Modarelli F; Pampanelli S; Perriello G; De Feo P; Brunetti P; Gerich JE
J Clin Invest; 1993 Oct; 92(4):1617-22. PubMed ID: 8408616
[TBL] [Abstract][Full Text] [Related]
9. Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis.
Gravholt CH; Møller N; Jensen MD; Christiansen JS; Schmitz O
J Clin Endocrinol Metab; 2001 May; 86(5):2085-9. PubMed ID: 11344211
[TBL] [Abstract][Full Text] [Related]
10. Role of insulin and free fatty acid (FFA) availability on regional FFA kinetics in the human forearm.
Capaldo B; Napoli R; Di Marino L; Guida R; Pardo F; Saccá L
J Clin Endocrinol Metab; 1994 Sep; 79(3):879-82. PubMed ID: 8077375
[TBL] [Abstract][Full Text] [Related]
11. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding.
Shaw JH; Wolfe RR
Ann Surg; 1987 Apr; 205(4):368-76. PubMed ID: 3105476
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone, glucagon, and insulin response to depression of plasma free fatty acids and the effect of glucose infusion.
Quabbe HJ; Ramek W; Luyckx AS
J Clin Endocrinol Metab; 1977 Feb; 44(2):383-91. PubMed ID: 838844
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
Simpson HL; Jackson NC; Shojaee-Moradie F; Jones RH; Russell-Jones DL; Sönksen PH; Dunger DB; Umpleby AM
J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
[TBL] [Abstract][Full Text] [Related]
15. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
16. Lipolytic response to glucose infusion in human subjects.
Wolfe RR; Peters EJ
Am J Physiol; 1987 Feb; 252(2 Pt 1):E218-23. PubMed ID: 3826340
[TBL] [Abstract][Full Text] [Related]
17. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
[TBL] [Abstract][Full Text] [Related]
18. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans.
Gormsen LC; Jessen N; Gjedsted J; Gjedde S; Nørrelund H; Lund S; Christiansen JS; Nielsen S; Schmitz O; Møller N
J Clin Endocrinol Metab; 2007 May; 92(5):1834-42. PubMed ID: 17341555
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.
Fanelli CG; De Feo P; Porcellati F; Perriello G; Torlone E; Santeusanio F; Brunetti P; Bolli GB
J Clin Invest; 1992 Jun; 89(6):2005-13. PubMed ID: 1602007
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
Møller N; Bagger JP; Schmitz O; Jørgensen JO; Ovesen P; Møller J; Alberti KG; Orskov H
J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
